Mesoblast Ltd Files Quarterly Report
Ticker: MEOBF · Form: 6-K · Filed: Aug 1, 2024 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Aug 1, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: quarterly-report, financial-update, sec-filing
TL;DR
MESO filed its quarterly report on 7/31, check the Appendix 4C for financial updates.
AI Summary
On July 31, 2024, Mesoblast Limited filed a quarterly report (Appendix 4C) with the Australian Securities Exchange. The report covers the period ending July 31, 2024, and details the company's financial activities. Mesoblast Limited is incorporated in Australia and its principal executive offices are located in Melbourne.
Why It Matters
This filing provides investors with an update on Mesoblast's financial status and operational activities for the past quarter, which is crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial information, not indicating any immediate or significant new risks.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- July 31, 2024 (date) — Filing date of quarterly report
- August 2024 (date) — Reporting period for Form 6-K
FAQ
What type of report did Mesoblast Limited file on July 31, 2024?
Mesoblast Limited filed a quarterly report (Appendix 4C) with the Australian Securities Exchange.
What is the reporting period for this Form 6-K?
The Form 6-K is for the month of August 2024, with information contained on this report filed as of July 31, 2024.
Who is the Chief Executive Officer of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
Where are Mesoblast Limited's principal executive offices located?
Mesoblast Limited's principal executive offices are located at Level 38, 55 Collins Street, Melbourne, 3000, Australia.
Under which SEC Act is this Form 6-K filed?
This Form 6-K is filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Filing Stats: 229 words · 1 min read · ~1 pages · Grade level 17.8 · Accepted 2024-07-31 21:34:07
Filing Documents
- a2024-08x01activitystateme.htm (6-K) — 20KB
- exhibit991.htm (EX-99.1) — 30KB
- exhibit991001.jpg (GRAPHIC) — 245KB
- exhibit991002.jpg (GRAPHIC) — 229KB
- exhibit991003.jpg (GRAPHIC) — 297KB
- exhibit991004.jpg (GRAPHIC) — 128KB
- exhibit991005.jpg (GRAPHIC) — 118KB
- exhibit991006.jpg (GRAPHIC) — 124KB
- exhibit991007.jpg (GRAPHIC) — 100KB
- exhibit991008.jpg (GRAPHIC) — 108KB
- exhibit991009.jpg (GRAPHIC) — 209KB
- exhibit991010.jpg (GRAPHIC) — 159KB
- exhibit991011.jpg (GRAPHIC) — 116KB
- 0001345099-24-000061.txt ( ) — 2576KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated August 1, 2024 INDEX TO EXHIBITS Item 99.1 Appendix 4C of Mesoblast Ltd, dated July 31 , 2024.